MENU

NBSE

Stock ticker:

PRICE

CHANGE

CAPITALIZATION

NeuBase Therapeutics (NBSE) Ownership - Who owns NeuBase Therapeutics?

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

350 Technology Drive

Phone

+1 412 763-3350

Employees

37

Web

https://www.neubasetherapeutics.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

1.42M

P/E Ratio

N/A

Total Cash

N/A

Projected Growth

N/A

Total Debt

N/A

Revenue

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

N/A

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for NBSE

A.I. Advisor

published General Information

General Information

a company, which engages in the development of drugs for patients with genetic neurological disorder.

Industry Biotechnology

Profile

Details

Industry

N/A

Address

350 Technology Drive

Phone

+1 412 763-3350

Employees

37

Web

https://www.neubasetherapeutics.com